US$ 26.29
digital health providers glp-1 weight loss Long-term Success of GLP-1s Hinges on More Than Just a Prescription Quantum Health Partners with Vida
Description
Analyses that have been done when comparing tirzepatide on Zepbounds side and semaglutide on Ozempics side indicate that Zepbound has a stronger ability to reduce weight

Should clinicians prescribe GLP-1 medications for Parkinsons disease now

#EDAW Really important data, especially around misuse patterns in a vulnerable population

Novos pill had a stronger first week than Lillys, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch on January 5
That's 35% more weight lossand the benefits extended beyond the scale
